Since 2008 THETA Collaborative has been hosting lecture series THETA Rounds and inviting world experts to address various issues related to Health Technology Assessment, Clinical Research and Health Policy and Ethics fields. From January 2016 onwards THETA Rounds are available in the live webinar format. Follow the individual session's title link to register for the webinar. In addition, recordings to past THETA Rounds 2019 -2008, containing recordings of full lectures, can be found below.
All our sessions are held at the following place and time; unless otherwise stated:
Place: *Please note* All rounds will be held virtually until further notice rather than our in office address of Toronto General Hospital, Eaton Building, 10th Floor, 200 Elizabeth St, Rm 10EB240.
Time: 1 - 2 pm
Webinar:
February 10
Economic evaluation of rehabilitation technologies: what are the unique challenges we face?
Brian C.F. Chan, PhD, is an Affiliate Scientist with the Neural Engineering and Therapeutics Team at KITE - Toronto Rehabilitation Institute and an Assistant Professor at the Institute of Health Policy, Management and Evaluation at the University of Toronto.
February 24
Title: TBD
Eleanor Pullenayegum, PhD, is a biostatistician whose primary work focuses on developing methodology for longitudinal data and health economics.
April 14
Title: TBD
Kednapa Thavorn, PhD, is a Senior Scientist and a Scientific Lead of Health Economics at the Ottawa Hospital Research Institute.
April 21
Title: TBD
Beate Sander, PhD, Canada Research Chair in Economics of Infectious Diseases, holds a Canada Research Chair in Economics of Infectious Diseases, is a Scientist of the Toronto Health Economics and Technology Assessment (THETA) collaborative at the Toronto General Hospital Research Institute, University Health Network (UHN), and Associate Professor at the Institute of Health Policy, Management and Evaluation (IHPME), University of Toronto.
May 5
Title: TBD
Uwe Siebert, PhD, Professor of Public Health, Medical Decision Making and Health Technology Assessment (HTA), is the Chair of the Department of Public Health, Health Services Research and HTA at UMIT – University for Health Sciences, Medical Informatics and Technology in Austria and the Director of the Division for HTA in the ONCOTYROL – Center for Personalized Cancer Medicine in Austria.
May 19
Title: TBD
Peter Neumann, PhD, is the Director, Center for the Evaluation of Value and Risk in Health at the Institute for Clinical Research and Health Policy Studies at Tufts Medical Center; Professor of Medicine, Tufts University School of Medicine
Recording
Speaker and Topic
Feb 19, 2021
The use of evidence-informed deliberative processes for HTA around the globe
Wija Oortwijn, PhD, senior researcher in the field of global HTA at the Radboud University Medical Centre in Nijmegen and as associate professor at Leiden University Medical Centre.
Feb 5, 2021
Does virtual care and remote automated monitoring (RAM) technology have the potential to represent a new paradigm to improve surgical safety
PJ Devereaux, MD, PhD, FRCP(C), cardiologist, clinical epidemiologist, and perioperative care physician.
Recording
Speaker & Topic
October 16, 2020
Economic Burden of Sepsis in Canada
Michelle Tew, PhD (c), is a health economics researcher at the Centre for Health Policy, Melbourne School of Population and Global Health.
June 12, 2020
Modeling the SARS-CoV-2 Epidemic in Rhode Island
TA Trikalinos, MD, PhD, founding director of the Center for Evidence Synthesis in Health at Brown University. His research is in methods and applications of evidence synthesis and decision making under risk and ambiguity.
Mar 6, 2020
HTA in Africa: Opportunities and Challenges
Murray Krahn, MD, MSc, FRCPC & Gebremedhin Gebretekle, PhD, MSc, BPharm.
Dr. Krahn is the Director of THETA, Tier 1 Canada Research Chair in Health Technology Assessment, and Professor in the Department of Medicine at the University of Toronto. Dr. Gebretekle is a Post-Doctoral Fellow in Health Services Research (Health Economics and Technology Assessment Stream) IHPME, University of Toronto.
Feb 21, 2020
A Non-Parametric Approach for Combining Evidence on Progression Free and Overall Survival Time
Caitlin Daly, PhD (c) & Nicky J. Welton, PhD.
Nicky is currently Professor of Statistical and Health Economic Modelling in the department of Population Health Sciences at the University of Bristol. Caitlin is currently Scientific Coordinator of the NICE Guidelines Technical Support Unit at the University of Bristol, while completing a PhD in Health Research Methodology at McMaster University.
Feb 07, 2020
23 and (not just) me: Incorporating family members in health technology assessment of genetic testing.
Wendy Ungar, PhD, Senior Scientist, Child Health Evaluative Sciences, Hospital for Sick Children Research Institute, and Professor, Institute of Health Policy, Management and Evaluation, University of Toronto, Canada. Dr. Ungar holds the Canada Research Chair in Economic Evaluation and Technology Assessment in Child Health. In 2007 Dr. Ungar founded TASK (Technology Assessment at Sick Kids), where she and her team conduct research applying health economic methods to child health with a focus on genomics and neurodevelopmental disorders.
Jan 24, 2020
Quantifying the value of further research to improve 21-gene assay decision-making in breast cancer
Natalia Kunst, MSc, PhD (c), Research Fellow at the Yale School of Medicine and a PhD Candidate in Health Decision Science at the University of Oslo, Norway.
Jan 10, 2020
Institutional Strategic Initiatives - understand supports for major inter-disciplinary initiatives at the University of Toronto
Vivek Goel, MD, CM, MSc, SM, FRCPC, Vice-President, Research and Innovation, and Strategic Initiatives at the University of Toronto; Professor in the Institute of Health Policy, Management and Evaluation at the Dalla Lana School of Public Health; Adjunct Senior Scientist, Public Health Ontario and Adjunct Senior Scientist, Institute for Clinical Evaluative Sciences.
Recording
Speaker & Topic
Dec 6, 2019
Value of Individualized Care.
David Patrick Glynn, MSc, MPharm, PhD(c), Research Fellow in the Team for Economic Evaluation and Health Technology Assessment (TEEHTA) at the University of York.
The recorded lecture will be posted after publication of results.
Nov 29, 2019
Just Coverage Decisions: Including Legal Analysis into the Assessment of Health Technologies
Colleen M. Flood FRSC FCAH, Professor at the University of Ottawa and a University Research Chair in Health Law & Policy. She is the inaugural director of the Ottawa Centre for Health Law Ethics and Policy.
Nov 22, 2019
The Feasibility and Cost of Hepatitis C Elimination - CANCELLED - may be rescheduled for a later date
Jagpreet Chhatwal PhD, Assistant Professor, Harvard Medical School, Senior Scientist, Institute for Technology Assessment, Massachusetts General Hospital and a decision scientist at MGH Institute for Technology Assessment (ITA).
Nov 8, 2019
The impact of patented drug price controls on drug launches: evidence from the OECD countries.
Paul Grootendorst, PhD,, Director of the Division of Social and Administrative Pharmacy in the Leslie Dan Faculty of Pharmacy, University of Toronto; Associate professor in the Faculty of Pharmacy, and the School of Public Policy and Governance, University of Toronto, Toronto, Canada; Adjunct associate professor in the Department of Economics, McMaster University in Hamilton, Canada; Associate editor of Health Economics.
Sept 18, 2019
Transplanting Hepatitis C Virus-Infected versus Uninfected Kidneys Into Hepatitis C Virus-Infected Recipients: A Cost-Effectiveness Analysis.
Mark H. Eckman, MD, MS, FACP, FACMI, Director - Division of General Internal Medicine, Department of Medicine, University of Cincinnati; Director - Center for Clinical Effectiveness, University of Cincinnati Medical Center; Posey Professor of Clinical Medicine - Department of Medicine, and Professor of Environmental Health , University of Cincinnati.
June 21, 2019
Underestimation of Variance of Predicted Mean Health Utilities Derived from Multi-Attribute Utility Instruments: The Use of Multiple Imputation as a Potential Solution.
Kelvin Kar-Wing Chan, MD, FRCPC, MSc, PhD, medical oncologist at the Sunnybrook Odette Cancer Centre, an associate professor at the University of Toronto, and an associate scientist at the Sunnybrook Research Institute. He specializes in GI oncology and head and neck oncology, Adjunct Scientist, ICES Central, Cancer Research Program, and
Eleanor Pullenayegum, BA, MA, PhD, a Senior Scientist at the Hospital for Sick Children and Associate Professor in the Dala Lana School of Public Health, at the University of Toronto.
June 7, 2019
Development, Assessment and Use of Microsimulation models in Medical Research
Stavroula Chrysanthopoulou, PhD, , an Assistant Professor of Biostatistics, the Department of Biostatistics at Brown University, Providence, Rhode Island, USA.
May 24, 2019
Smartwatch Monitoring of Patients with COPD
Robert Wu, MD, FRCPC, MSc, Clinical Researcher, Toronto General Hospital Research Institute (TGHRI), UHN; Assistant Professor, the Department of Medicine, the University of Toronto.
May 10, 2019
OncoSim – a free cancer simulation tool
Jean Yong, MASc, a consultant for the Canadian Partnership Against Cancer, she is part of the OncoSim team.
April 26, 2019
Innovative Pediatric Clinical Trials: Methodological and logistical challenges
Terry Klassen, MD, MSc, FRCPC, Director of Research for the Manitoba Institute of Child Health (MICH); Associate Dean, Academic, Faculty of Medicine; Director of Research for the Department of Pediatrics and Child Health, University of Manitoba; and Pediatric Emergency Physician, Child Health Program, Winnipeg Health Region; Academic Director, The George & Fay Yee Centre for Healthcare Innovation (CHI); an advisor with EvidenceNetwork.ca.
April 26, 2019
Topic 1: Development of a disease history model for Zika virus (ZIKV) infection - A microsimulation model
Raphael Ximenes, PhD, Postdoctoral fellow at Toronto General Hospital Research Institute/ THETA.
Topic 1: State-specific direct medical costs of Hepatitis C in Ontario: A population-level study
Alex Haines, MSc, Health Economist at THETA Collaborative.
March 22, 2019
Real-world studies in China: Opportunities and Challenges.
Wendong Chen, MD, PhD, Founder and President of Normin Health, Toronto, Canada and China.
March 8, 2019
Modeling the Cost Effectiveness of Two Big League Pay-for-Performance Policies.
Ankur Pandya, MPH, PhD, an Assistant Professor of Health Decision Science in the Department of Health Policy and Management at the Harvard T.H. Chan School of Public Health.
February 22, 2019
A research smorgasbord: Behavioral, mathematical, and philosophical perspectives on health utility and medical decision-making.
Bart S Ferket, MD, PhD, Department of Population Health Science & Policy, Mt Sinai Hospital, NY.
January 25, 2019
A research smorgasbord: Behavioral, mathematical, and philosophical perspectives on health utility and medical decision-making.
Barry Dewitt, PhD, the Department of Engineering & Public Policy, Carnegie Mellon University, an MSc in Mathematics and the Foundations of Computer Science from the University of Oxford, and a B. Arts & Sci in mathematics from McMaster University.
January 11, 2019
User Involvement in Technology Development and Evaluation
Holly Witteman, PhD, an Associate Professor in the Department of Family & Emergency Medicine, Université Laval (Laval University), Quebec City, Canada.
Recording
Speaker & Topic
Dec 7, 2018
Learning from the Moo Pa Academy Soccer Team experience in Thailand: Health Technology Assessment (HTA) in Southeast Asia
Wanrudee Isaranuwatchai, PDF, PhD is an Interim Director and a Health Economist at the Centre of Excellence for Economic Analysis Research (CLEAR) at St. Michael’s Hospital, and an Assistant Professor at the Institute of Health Policy, Management and Evaluation at the University of Toronto.
Nov 23, 2018
Unexplained Confounding? A Case Study in Propensity Score Analysis.
Lusine Abrahamyan, MD, MPH, PhDClinical Epidemiologist, Toronto Health Economics and Technology Assessment (THETA) Collaborative, University Health Network; Assistant Professor (CLTA), the Institute of Health Policy, Management and Evaluation at the University of Toronto; Assistant Professor (Visiting), School of Public Health, American University of Armenia, Yerevan, Armenia; Assistant Professor, Leslie Dan faculty of Pharmacy (cross-appointed).
Nov 9, 2018
TECHNA – Advancing Health Technology.
Luke Brzozowski, PhD, leads TECHNA’s Technology Team and the Research Office of the Joint Department of Medical Imaging.
Oct 26, 2018
Next generation data technology - Bridging the gap between predictive analytics and clinical medicine.
Cedric Manlhiot, PhD, Cardiovascular Data Management Centre, University of Toronto; Associate Scientist, The Hospital for Sick Children and the University Health Network Research Institute; Assistant Professor, Faculty of Medicine, University of Toronto.
Oct 19, 2018
Potential for Hepatitis C elimination? - Modelling future spread and cost-effectiveness of interventions from a Norwegian perspective.
Torbjørn Wisløff, MSc, PhD, Senior Scientist, Infectious Diseases Epidemiology and Modelling at the Norwegian Institute of Public Health and Associate Professor at the Department of Health Management and Health Economics (HELED) at the University of Oslo
Oct 12, 2018
Methods for measuring and valuing health gains for cost-utility analysis: Current approaches and new insights into framing effects.
Natalie Carvalho, BSc, MPH, PhD, Senior Research Fellow at the Melbourne School of Population and Global Health. She holds a joint appointment with the Global Burden of Disease Group and the Health Economics Unit at the Centre for Health Policy.
No recording.
Sept 28, 2018
Sin taxes to improve population diets? Effectiveness and cost-effectiveness of the soda tax implemented in Chile.
Cristóbal Cuadrado, MD, MPH, PhD(c), Assistant Professor, Program of Health Policy, Systems and Management - School of Public Health, University of Chile and PhD student in Public Health, University of Chile.
Sept 14, 2018
Therapeutic Benefit of a Clinically Organized Digital Counseling Protocol for Hypertension and Chronic Heart Failure
Rob Nolan, PhD, C.Psych., Director, Cardiac eHealth and Behavioural Cardiology Research Unit, PMCC-UHN; Senior Scientist, Toronto General Research Institute; Associate Professor, Faculty of Medicine, University of Toronto
Jun 8, 2018
Health equity: monitoring performance and confronting trade-offs.
Dr. Shehzad Ali, PhD, Director, Cardiac eHealth and Behavioural Cardiology Research Unit, PMCC-UHN; Senior Scientist, Toronto General Research Institute; Associate Professor, Faculty of Medicine, University of Toronto.
May 25, 2018
Accessing CCO data for research purposes.
Nicole Mittmann, MSc, PhD Associate scientist (cross appointed), Evaluative Clinical Sciences, Trauma, Emergency & Critical Care Research Program, Sunnybrook Research Institute; Chief research officer, Cancer Care Ontario; Adjunct faculty, International Centre for Health Innovation, Richard Ivey School of Business; Assistant Professor, Department of Pharmacology, University of Toronto.
Apr 27, 2018
Improving discrimination of the Health Utilities Index, Mark 3 for hearing states associated unilateral and bilateral cochlear implants.
Peter Dixon MD, Resident in the Department of Otolaryngology - Head and Neck Surgery and MSc student in Clinical Epidemiology and Healthcare Research at Institute of Health Policy, Management & Evaluation, University of Toronto.
Apr 13, 2018
Drinking from the fire hose: Opportunities and challenges of empowering patients in the era of genome sequencing.
Yvonne Bombard, BSc, PhD, PDF, Scientist at the Li Ka Shing Knowledge Institute of St. Michael’s Hosp.; Assistant Professor, IHPME, University of Toronto.
Mar 16, 2018
Understanding value in personalized monitoring of therapeutic outcomes in oncology: Prospects and caveats.(Lecturer did not permit recording)
Dr. Ioannis Prassas, a Staff Scientist at Mount Sinai Hospital.
Mar 2, 2018
Decision theoretic methods for optimal timing of longitudinal biomarker collection.
Aasthaa Bansal, PhD, Assistant Professor, The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute, Department of Pharmacy, University of Washington.
Feb 16, 2018
What informs clinical decisions about medical device use and adverse event reporting.
Anna Gagliardi, MSc, PhD, MLS, a Scientist at the Toronto General Hospital Research Institute (TGHRI), Associate Professor, Department of Surgery; Institute of Health Policy, Management & Evaluation; and Institute of Medical Science, University of Toronto, and Chair, Implementation Working Group, Guidelines International Network.
Feb 2, 2018
Extra-corporeal membrane oxygenation: cost-effectiveness in the context of critical care.
Kali Barrett, MD, MSc, Critical Care Physician, University Health Network. Bio & Lecture Abstract
Jan 19, 2018
New Era of HTA; Overview of International Best Practices (Note: recording is missing a few initial minutes of the lecture.)
Hamid Sadri, PharmD, MSc, , Director Health Economics and Health Technology Assessment at Medtronic.
Jan 5, 2018
Treatment decisions in Chronic Kidney Disease: Revenge of the Sith. (Note: recording is missing a few initial minutes of the lecture.)
David Naimark, MD, MSc, Assistant Professor of Medicine, U of T; Staff Nephrologist, Sunnybrook Health Sciences Centre.
Recording
Speaker & Topic
Dec 8, 2017
Developing a ‘Precision Medicine Ready’ reference policy model for COPD: challenges, rewards, and lessons learned.
Mohsen Sadatsafavi, MD, PhD,, Assistant Professor, Health Outcomes, UBC Scientist, Centre for Clinical Epidemiology and Evaluation, University of British Columbia.
Nov 24, 2017
Preferences for New HIV Prevention Technologies among Men who have Sex with Men: A Discrete Choice Experiment.
Ahmed Bayoumi MD MSc FRCPC, Scientist, Centre for Urban Health Solutions, Li Ka Shing Knowledge Institute; HIV & internist physician, St. Michael's Hospital. (Note: video only, no audio)
Oct 13, 2017
Zero price cost-effectiveness: are some patients too expensive to keep alive?
Alex Haines, MSc Health Economist, THETA Collaborative.
Aug 04, 2017
Health economics, public health, public goods and the circular economy.
Rhiannon Tudor Edwards BSc. Econ, M.A., D.Phil., Hon. MFPH, FLSW Professor of Health Economics and the founding Director of health economics research at Bangor University and is now Co-Director of the Centre for Health Economics and Medicines evaluation (CHEME), Bangor University. Rhiannon is also Director of the Welsh Health Economics Support Service (WHESS, funded by NISCHR).
Jun 16, 2017
Research Possibilities in Central Africa.
Philip Wood, MA FRCS and Nancy Houser Wood, BSc MD, recounted their work in Congo and described research needs and collaboration/mentoring opportunities for students of Medical and Nursing Colleges in Christian University in Bunia and Université Shalom de Bunia, Congo. Read more about their 40 years work in Congo in the Toronto Star article Aug. 20, 2012.
Jun 9, 2017
Trends in medical cannabis use in Canada, 2001-2016.
Paul Grootendorst, PhD, Director of the Division of Social and Administrative Pharmacy in the Leslie Dan Faculty of Pharmacy, University of Toronto; Associate professor in the Faculty of Pharmacy, and the School of Public Policy and Governance, University of Toronto, Toronto, Canada; Adjunct associate professor in the Department of Economics, McMaster University in Hamilton, Canada; Associate editor of Health Economics.
May 19, 2017
How can economic evaluation inform cost reduction and disinvestment in the hospital setting?
Ava John Baptiste, PhD, Assistant Professor at the Schulich Interfaculty Program in Public Health; health economist in the Centre for Medical Evidence, Decision Integrity and Clinical Impact (MEDICI).
May 12, 2017
The potential of open access tools for health planning and modelling: a case study of the Propensity to Cycle Tool.
http://www.pct.bike/
Robin Lovelace, PhD, University Academic Fellow in Transport and Big Data at the Leeds Institute for Transport Studies (ITS), UK. Short Bio & Abstract
(due to technical difficulties recording is not available for the first few minutes of the session)
Date | Speaker & Topic |
Apr 21, 2017 | Value-based decision-making from different perspectives: case studies from rheumatoid arthritis. Nick Bansback, PhD, CHÉOS Program Head - Decision Sciences; Assistant Professor, School of Population and Public Health, UBC Short Bio |
Mar 24, 2017 | The promise and pitfalls of Remote Patient Monitoring. Heather Ross, BSc, MHSc, MD, FRCPC, FACC, Professor of Medicine at the University of Toronto, Director of the Ted Rogers Centre of Excellence in Heart Function and holder of the Ted Rogers and Family Chair in Heart Function, Affiliate Scientist, Toronto General Research Institute (TGRI). Short Bio |
Mar 10, 2017 | Policy and Economics Research in Childhood Cancer (PERCC) Centre. Sumit Gupta, MD, PhD, FRCPC Oncologist and Clinician Investigator at the Hospital for Sick Children, an Assistant Professor at both the Faculty of Medicine and the Institute for Health Policy, Management and Evaluation at the University of Toronto, and an Adjunct Scientist with the Cancer Research Program at the Institute for Clinical Evaluative Sciences |
Feb 10, 2017 | Value of Information (VOI) and Meta Modelling. Hawre Jalal, MD, PhD, Assistant Professor at the Department of Health Policy and Management, University of Pittsburgh. |
Jan 27, 2017 | Canadian Publicly Funded Prescription Drug Plans, Expenditures and an Overview of Patient Impacts. Fiona Clement, PhD, Assistant Prof and Director of HTA Unit, O’Brien Institute of Public Health at the University of Calgary. |
Jan 20, 2017 | Beate Sander, PhD, Scientist at Public Health Ontario; Assistant Professor at the IHPME, University of Toronto; Adjunct Scientist at ICES; Investigator at THETA. (due to technical difficulties audio is not available for the first 16 min 16 sec of the session) |
Jan 13, 2017 | Valeria E. Rac, MD PhD, Associate Program Director and Director, Clinical Research Division, THETA Collaborative; Assistant Professor, IHPME & Faculty of Pharmacy, University of Toronto. |
Date | Speaker & Topic |
Dec 16, 2016 | Peter Cram, MD, MBA,Director of Division of General Internal Medicine at Mt. Sinai/UHN Hospitals, Professor of Internal Medicine at the University of Toronto : If we mail patients their bone density results, does anything happen? Results from the NIH-funded PAADRN study (due to technical difficulties audio is available for last 30 min of the session) |
Dec 02, 2016 | Claire de Oliveira, PhD, an Independent Scientist and Health Economist with the Institute for Mental Health Policy Research at CAMH, and an Assistant Professor in the Institute of Health Policy, Management and Evaluation (IHPME) at the University of Toronto : The role of mental health and addiction among high-cost patients. |
Nov 18, 2016 | Deb Marshall, PhD Canada Research Chair, Health Services and Systems Research as an Associate Professor at the University of Calgary and Arthur J.E. Child Chair of Rheumatology Outcomes Research in the McCaig Institute of Bone and Joint Health, the Director of Health Technology Assessment at the Alberta Bone and Joint Health Institute, a Senior Scientist of the Arthritis Research Center of Canada, and a member of the Institute of Public Health : A Different View: What it Looks Like When you Listen to Patients . (recording will be released upon author's approval) |
Nov 4, 2016 | Carolina Alba, MD, PhD University Health Network Department of Cardiology Toronto, Canada : Prognosis in current heart failure patients. A new approach for predictive model development. |
Oct 21, 2016 | Andrea Gershon, MD, M.Sc. Scientist and Research director, Sunnybrook Health Sciences Centre and Institute for Clinical Evaluative Sciences : The Ontario COPD Population Health Network |
Oct 7, 2016 | Hawre Jalal, MD, PhD, Assistant Professor at the Department of Health Policy and Management, University of Pittsburgh, and at the Public Health Dynamic Laboratory; : Examining the Opioid Epidemic from a Public Health Perspective (Audio starts after 2m 34s) |
Sept 23, 2016 | George Tomlinson, PhD Director of Biostatistics Research Unit, UHN : Exploring the use of decision thresholds for ranking treatments in network meta-analysis (Audio starts after 4 min) |
Sept 9, 2016 | Evaluation of the BresoDx® Portable Monitor for the Diagnosis of Obstructive Sleep Apnea – study results (due to technical difficulties audio is not available for this session) Dr. Valeria E. Rac, an Associate Program Director and Director, Clinical Research Division at THETA Collaborative, and an Assistant Professor, at the Institute of Health Policy, Management and Evaluation and the Leslie Dan Faculty of Pharmacy, University of Toronto.Dr. Lusine Abrahamyan, a Clinical Epidemiologist at THETA Collaborative, and an Assistant Professor, at the Institute of Health Policy, Management and Evaluation and the Leslie Dan Faculty of Pharmacy, University of Toronto. Dr. Petros Pechlivanoglou, Scientist at Child Health Evaluative Sciences, Sick Kids Hospital. Evaluation of the BresoDx® Portable Monitor for the Diagnosis of Obstructive Sleep Apnea – study results (due to technical difficulties audio is not available for this session) |
Jun 17, 2016 | Harindra Wijeysundera, MD, PhD, FRCPC, Scientist, Schulich Heart Research Program, Sunnybrook Research Inst, Asst professor, IHPME and Dept of Medicine, UofT : Appropriate Use Criteria in the Diagnosis and Management of Coronary Artery Disease: Insights from a Provincial Registry (Audio good after first 4 min) |
May 20, 2016 | Mark Sculpher, PhD, Professor of Health Economics and Director of the Programme on Economic Evaluation and Health Technology Assessment University of York, UK Murray Krahn, MD, MSc, FRCPC, Director of THETA, the F. Norman Hughes Chair in Pharmacoeconomics and Social and Administrative Pharmacy Division Head in the Faculty of Pharmacy, Professor at the University of Toronto, and Scientist and Adjunct Scientist at the Toronto General Research Institute and Institute for Clinical Evaluative Sciences |
May 6, 2016 | Diarmuid Coughlan, MPharm, MSc (Health Econ), PhD, Cancer Prevention Fellow at Surveillance Research Program, National Cancer Institute, US : Medical Costs’ and ‘Financial Toxicity’ of Cancer Care in the USA (only abstract available) |
Apr 22, 2016 | Lauren Cipriano, PhD, Assistant Professor in Management Science, Ivey Business School, Western University, London, ON : Evaluating patient prioritization schemes for hepatitis C treatment under budget constraints |
Apr 15, 2016 | Bruce Y. Lee, MD, MBA, Associate Professor of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD : Systems Modeling in Public and Global Health |
Apr 8, 2016 | Janel Hanmer, MD, PhD, Assistant Professor of Medicine, University of Pittsburgh, US : Construction of a preference-based summary score for the Patient Reported Outcomes Measurement Information System (PROMIS) |
Mar 18, 2016 | Tom Trikalinos, PhD, Associate Professor of Health Services, Policy and Practice, Director of Evidence-Based Medicine, Brown University, Rhode Island, US : Decision-making under competing interpretations of the evidence: Application in prostate cancer screening (due to technical difficulties first 10min of the lecture are not available) |
Mar 4, 2016 | Eva Enns, PhD, Assistant Professor, Health Policy & Management, University of Minnesota, US : Identifying Best-fitting Inputs in Multi-target Model Calibration (due to technical difficulties first 6min of the lecture are not available) |
Feb 19, 2016 | Gianluca Baio, Msc, PhD, Department of Statistical Sciences at University College London (UK). : Value of Information in practice. No, seriously: in practice! |
Feb 5, 2016 | David Henry, MB ChB, MRCP, FRCP, Professor of Health Systems Data, co-lead for "Big Data for Health" initiative at the IHPME and Dalla Lana School of Public Health, University of Toronto. : Opportunities Created by the Changing Landscape of Health Data |
Jan 15, 2016 | Murray Krahn, MD, MSc, FRCPC, Director of THETA, the F. N. Hughes Chair in Pharmacoeconomics and Social and Administrative Pharmacy Division Head, Faculty of Pharmacy, Professor at the University of Toronto, and Scientist and Adjunct Scientist at the Toronto General Research Institute and Institute for Clinical Evaluative Sciences, respectively, active physician General Internal Medicine at the University Health Network, Toronto. : Developing a Values Based Framework for Decision Making in Technology Assessment (and Health) |
Date | Speaker & Topic |
Feb 5, 2016 | David Henry, MB ChB, MRCP, FRCP, Professor of Health Systems Data, co-lead for "Big Data for Health" initiative at the IHPME and Dalla Lana School of Public Health, University of Toronto. : Opportunities Created by the Changing Landscape of Health Data |
Dec 18, 2015 | Feng Xie, BSc, MSc, PhD, Associate Professor, Dept of Clinical Epidemiology & Biostatistics; Acting Assistant Dean, Faculty of Health Sciences, McMaster University : Health utility for coverage decision making: imagination, prediction, or deception? |
Dec 4, 2015 | Janet Parson, PhD, Scientist, Li Ka Shing Knowledge Institute; Assistant Professor, Dept of Physical Therapy, and CQ Fellow Dalla Lana School of Public Health, University of Toronto : On being an outlier: Participatory arts-based research methods in the service of practice and policy |
Nov 20, 2015 | Andrea Tricco, PhD, Scientist, Li Ka Shing Knowledge Institute; Assistant Professor, Dalla Lana School of Public Health, University of Toronto : Does it matter: timeliness or accuracy of results? The choice of rapid reviews or systematic reviews to inform decision-making. |
Nov 6, 2015 | Noemi Kreif, PhD, Research Fellow in Health Economics , London school of Hygiene and Tropical Medicine. Estimating the causal effects of longitudinal treatment regimes: an application in critical care |
Oct 23, 2015 | Beate Sander, PhD, Scientist, Public Health Ontario, Assistant Professor, IHPME, University of Toronto, Adjunct Scientist, ICES : Humans, Mosquitoes, Birds & The Environment: Evaluating West Nile Virus Mitigation Strategies |
Oct 9, 2015 | Michael Hillmer, PhD, Director - Planning, Research and Analysis Branch, OMHLTC, Assistant Professor , Institute of Health Policy, Management and Evaluation, U of Toronto : Health Services Research and Policy Making in Ontario |
Sep 11, 2015 | Iben Fasterholdt, PhD student / HTA consultant at University of Southern Denmark (SDU) and Odense University Hospital (OUH), Denmark : Telemedicine in DK/Europe – are we evaluating early enough? |
May – Sept, 2015 | Summer Break |
May 1, 2015 | Mike Kattan, PhD, Quantitative Health Sciences, Cleveland Clinic Main Campus, Cleveland, OH. : Statistical Prediction Models and Medical Decision Making |
Apr 10, 2015 | David Paltiel, PhD, Yale School of Public Health : Reducing Sexual Violence by Increasing the Supply of Toilets in Khayelitsha, South Africa |
Mar 20, 2015 | Robin Hayeems, ScM, PhD, Scientist-track Investigator at Sick Kids Hospital : Whole genome sequencing in pediatrics: current ethical controversies |
Mar 6, 2015 | J. Jaime Caro, MDCM, FRCPC, FACP, Chief Scientist at Evidera, adjunct Professor at McGill University : Rolling the DICE: can we do better than Markov, DES, and Microsimulation? (Note: due to technical difficulties audio unclear for the first 24 min) |
Feb 20, 2015 | Natasha Stout, PhD, Assistant Professor, Population Medicine, Harvard Medical School : Screening breast MRI: Emerging trends in community use. |
Feb 6, 2015 | Wendy Ungar MSc, PhD Senior Scientist at Sick Kids Hospital : Economic Evaluation and Child Health: Will the growth spurt be sustained? |
Jan 23, 2015 | William Wong, PhD, THETA and Assistant Professor at the Faculty of Pharmacy, University of Toronto : Cost-Effectiveness of Screening for Hepatitis C in Canada |
Jan 9, 2015 | Eleanor Pullenayegum MA, PhD, Biostatistics, University of Toronto : Statistical analysis of matched longitudinal cost data. |
Date | Speaker & Topic |
Dec 13, 2013 | Courtney Davis, PhD, King's College, London, UK: Mapping recent and current trends in pharmaceutical regulation: implications for innovation, safety and the cost-effective use of new medicines |
Nov 29, 2013 | Stuart Hogarth, PhD: From Papanicolaou to Papilloma: the corporatisation of cancer screening innovation |
Nov 8, 2013 | Heather Taffet Gold, PhD, Associate Professor, Department of Population Health, Associate Professor, Department of Orthopaedic Surgery, Director, Population Health Research, Department of Orthopaedic Surgery, NYU School of Medicine, New York, US: Adoption and cost effectiveness of breast cancer radiotherapy technologies: Quantitative and qualitative evaluation |
Oct 4, 2013 | Lisa Prosser, Ph.D.Professor, Department of Pediatrics and Communicable Diseases Medical School and Professor, Department of Health Management and Policy, University of Michigan: Comparative Effectiveness and Child Health |
Sep 20, 2013 | Petros Pechlivanoglou MSc, PhD: An introduction to network meta-analysis (methods and applications) and why we should care about it. |
Sep 6, 2013 | Ba' Pham, MSc, PhD(c): Developing methods for the estimation of the cost-effectiveness threshold for cost-effectiveness analysis |
May – Sept, 2013 | Summer Break |
May 31, 2013 | Andy Willan: Value and uncertainty in pricing new health care interventions |
May 17, 2013 | Scott Grosse: Challenges in Assessing the Economic Value of Treatments for Rare Disorders: Prophylaxis in Hemophilia |
May 3, 2013 | Jeremy Goldhaber-Fiebert: Tuberculosis, Drug Resistance, and The Potential Effectiveness of Multiple Types of Interventions: Mathematical Modeling for Policy Analyses |
April 19, 2013 | Kamran Khan: Evaluating the Immigration Screening Process for the Prevention and Early Detection of Active Tuberculosis |
April 5, 2013 | Pascale Lehoux: The Interactions Between Business Models and Health Technology Design: A Comparative Analysis of Three Academic Spin-Offs |
March 22, 2013 | Mike Paulden: Advancing the methods of cost-effectiveness analysis: why it's time to move on from ICERs and thresholds |
March 8, 2013 | Hai Nguyen: Ontario's generic drug pricing policy |
February 22, 2013 | Craig Mitton: Priority setting in health care: lessons learned and next steps |
February 8, 2013 | THETA Rounds are CANCELLED due to inclement weather |
January 25, 2013 | Onil Battacharrya, MD, PhD and Michael Schull, MD, MSc, FRCPC: BRIDGES: creation of an incubator for health system integration and evaluation. |
January 17, 2013 | Special THETA Rounds presentation: Dr. Stirling Bryan: Are we suffering an addiction to adoption in health economics? |
January 11, 2013 | Walter Wodchis: Person-centered Costing Using Administrative Data |
December 14, 2012 - Ba' Pham, MSc, Decision Modeler: Calibration of decision models – A non-technical overview of a conceptual framework and literature review
December 7, 2012 - Laurie Lambert: Field evaluations of cardiac care: lessons learned by the tertiary cardiology unit of illnesses.
November 23, 2012 - Michael Iskedjian: Determining the monetary value of a QALY: From which perspective and whose preference?
November 16, 2012 - Antoine Boivin, MD, PhD: Involving the public in healthcare priority setting: moving from rhetoric to action(Resources only)
November 2, 2012, 1pm - Sarah Bermingham, BSc, MSc: A NICE perspective
October 5, 2012, 1 pm - Muhammad Mamdani, PharmD, MA, MPH: Bridging Drug Policy and Research: The Ontario Drug Policy Research Network
September 21, 2012, 1pm - Dr. Joseph Cafazzo, PhD PEng: Patient, Health Thyself: Self-care facilitated by mHealth
September 7, 2012, 1pm - Dr. Joel Lexchin: Evergreening: Patents and Money
June 1, 2012, 12pm - Petros Pechlivanoglou: Intergrating network meta-analysis and decision analytic modeling in a common framework
May 4, 2012, 12pm - Rumona Dickson: HTA and the establishment of health policy in the UK: working in the NICE appraisal process
April 27, 2012, 12pm - Tina Shih: Important advances in cost-effectiveness analysis
April 13, 2012, 12pm - Christopher S. Hollenbeak: The implications of cancer survivorship for spousal employment
March 23, 2012, 12pm - Open Debate: Open debate: Cost-effectiveness analysis is not useful in the real world
March 9, 2012, 12pm - Rosie Thein and William Wong: Model-based evaluation of prevention and treatment interventions for hepatitis C
March 2, 2012, 12pm - Dante Morra: The Innovated A-Fib Project - Implementing Disease Specific Value Based Care
February 24, 2012, 12pm - Mireille Goetghebeur: What MCDA EVIDEM can bring to the HTA table.
February 10, 2012, 12pm - Farzad Ali: Early payer engagement by industry: Can we afford not to do it?
January 27, 2012, 12pm - Mona Sabharwal: The pan-Canadian Oncology Drug Review: facts, fallacies and frequently asked questions.
December 16, 2011, 12pm - Karen Born and Andreas Laupacis: Promoting health policy literacy via the social web. The case ofwww.healthydebate.ca
December 2, 2011, 12pm - Janet Martin: Do you know Know4Go? Full contact HTA in the real world
November 18, 2011, 12pm - Dr. Peter Anglin: Offering cancer patients who can afford it access to high-priced new drugs the public system does not fund
November 4, 2011, 12pm - David Naimark: PRO: The half-cycle correction explained: two alternative pedagogical approaches. CON: The Half-Cycle Correction: Banish Rather Than Explain It
October 7, 2011, 12pm - Karen Lee: Recent Issues in Formulary Submissions
September 23, 2011, 12pm - Peter Neumann: Cost-Effectiveness Analysis in U.S. Health Care: Trends, Myths, and Future Directions
September 9, 2011, 12pm - William Witteman: Demythologizing the high costs of pharmaceutical research
August 12, 2011, 12pm - Sarah Garner: A NICE update
May 20, 2011, 12pm - Claire de Oliveira: Measuring the ROI on Cardiovascular Disease Research for the Institute of Circulatory and Respiratory Research at CIHR
May 6, 2011, 12pm - Li Ka Shing Knowledge Institute Presents Stephen Duckett: "Will ageing bankrupt the health system? If not, why not?"
April 8, 2011, 12pm - Don Husereau: The Relevance of Ignorance and Other Future Challenges for HTA
March 11, 2011, 12pm - Irfan Dhalla: Perspectives on NICE's recommendations to use technologies only in research
February 11, 2011, 12pm - Mike Paulden: Investment and disinvestment of health technologies: the need for two cost-effectiveness thresholds
January 28, 2011, 12pm - Dr. Stirling Bryan: Outcome-based Performance Metrics in Health Care: Has Their Time Come?
January 14, 2011, 12pm - David Shum: Industry perspectives of HTA
December 17, 2010, 12pm - Thérèse Stukel: In Healthcare, Is More Always Better?
December 3, 2010, 12pm - Mike Paulden: The NICE cost-effectiveness threshold: what it is and what that means
November 12, 2010, 12pm - Iris Lansdorp-Vogelaar: MISCAN-Colon: a microsimulation model to estimate the effects of colorectal cancer screening on population health
November 5, 2010, 12pm - David Meltzer: The Importance of Self-selection in Medical Cost-effectiveness Analysis
October 22, 2010, 12pm - Anirban Basu: Estimating lifetime or episode-of-illness costs under censoring
October 20, 2010, 12pm - Maurice McGregor: How to Get the Most Out of HTA - SPECIAL WEDNESDAY ROUNDS
October 8, 2010, 12pm - David Fisman: Modelling an influenza pandemic: A guide for the perplexed
September 17, 2010, 12pm - Gerald Evans: Reality Bites: Tales from the CED
September 10, 2010, 12pm - Guillermo Sandoval: The Alternate Level of Care (ALC) Challenge: Potential areas for cost-effectiveness analysis
May 28, 2010, 12pm - THETA Retreat (No Rounds)
May 21, 2010, 12pm - Martin Brown: Recent Developments in Cancer Comparative Effectiveness Research in the United States: Opportunities and Challenges
April 30, 2010, 12pm - Eyal Cohen: Cost-effectiveness of Competing Strategies for the Treatment of Pediatric Empyema
April 16, 2010, 12pm - Stephanie Van Bebber: The Decision Maker's Toolbox: Fitting A Round Peg Into A Square Hole?
March 12, 2010, 12pm - Marc Brisson: Impact of structural uncertainty on predictions of HPV vaccine effectiveness: A comparative model-based analysis
March 5, 2010, 12pm - Konrad Fassbender: Economics of Palliative and End of Life Care
February 19, 2010, 12pm - Colin Vicente: How pharmaceutical pricing decisions are made - a local industry perspective
February 12, 2010, 12pm - Paul Grootendorst: Instrumental Variables Estimation
February 5, 2010, 12pm - Deborah Marshall: HSR and HTA: Bosom Buddies in the economic evaluation of personalized breast cancer drugs?
January 29, 2010, 12pm - Mark Sculpher: Reflecting uncertainty in cost-effectiveness: moving beyond technical analyses to inform policy questions
January 29, 2010, 12pm - Mark Sculpher: Reflecting uncertainty in cost-effectiveness: moving beyond technical analyses to inform policy questions
January 22, 2010, 12pm - Hugh Walker: The "Best Use" of Cancer Drugs When Financial and Professional Resources are Limited
January 15, 2010, 12pm - Gloria Woo: Evolving paradigms in the treatment of hepatitis B
January 8, 2010, 12pm - Nicole Mittmann: Through the Looking Glass: Economics and Cancer
December 18, 2009, 12pm - Warren Chin: Involving Stakeholders in Healthcare Decisions
December 4, 2009, 12pm - Rebecca Hancock: An economic evaluation of teratology information services
November 20, 2009, 12pm - Parneet Cheema: Reimbursement of New Cancer Therapeutics: A Global Perspective
November 13, 2009, 12pm - Sara Khor: Ontario's formulary committee: how recommendations are made
October 23, 2009, 12pm - Jean Yong: Representing Uncertainty: The Role of Cost-Effectiveness Acceptability Curves
October 9, 2009, 12pm - Katia Noyes: Certainly uncertain: economic evaluations of healthcare interventions in the US
September 25, 2009, 12pm - Wendy Ungar: From Beijing to Xin Hua and back again. A Canadian's view of Chinese health care reform
September 11, 2009, 12pm - Michael Carter: Can Healthcare Engineering Models Influence Policy Decisions?
June 12, 2009, 12pm - Susan Griffin: Dangerous Omissions: The Consequences of Ignoring Decision Uncertainty
June 11, 2009, 12pm - Andrew Briggs: Statistical Methods for Health Economic Evaluation: Current trends and future directions
May 29, 2009, 12pm - Mark Roberts: Virtual Clinical Trials: Gaining Biological Insights Through Mathematical Models
May 15, 2009, 12pm - Ava John-Baptiste: Cost-effectiveness acceptability curves - facts, fallacies and frequently asked questions
May 8, 2009, 12pm - Matthew Kowgier: Cost-effectiveness analysis of a multinational RCT
May 1, 2009, 12pm - Michael Drummond: Is the QALY in Terminal Care?
April 17, 2009, 12pm - Marcio Machado: Heterogeneity in data combination: the good, the bad, and the ugly
April 3, 2009, 12pm - Luciano Ieraci: Cost estimation using regression, re-transformation and smoothing
March 18, 2009, 12pm - Karl Claxton: On the eve of the mother of all battles: prospects for NICE
March 6, 2009, 12pm - Angela Rocchi: The Role of Economic Evidence in Canadian Oncology Reimbursement Decision-Making: To Lambda and Beyond
February 20, 2009, 12pm - William Witteman: Potential of electronic personal health records
February 6, 2009, 12pm - Merrick Zwarenstein: Pragmatic trials: back to the future for the randomised clinical trial
January 23, 2009, 12pm - Marcio Machado: Expected Value of Perfect Information: An Empirical Example of Reducing Decision Uncertainty by Conducting Additional Research
January 9, 2009, 12pm - Greg Zaric: The cost-effectiveness of Vancouver's supervised injection facility
December 12, 2008, 12pm - Wendy Ungar and Vania Costa: Health Technology Assessment of caspofungin in the empiric treatment of children with febrile neutropenia
November 28, 2008, 12pm - Fiona Miller: The Relationship Between Academic Technology Transfer for Health Innovation and Health Technology Assessment
November 14, 2008, 12pm - Rinku Sutradhar: Clustered Progressive Multi-State Processes Under Incomplete Observation: Application to Joint Damage in Psoriatic Arthritis
October 31, 2008, 12pm - Ba' Pham: Calibration Analysis of Decision Analytic Models for Economic Evaluation
October 17, 2008, 12pm - Eleanor Pullenayegum: Inferring causal relationships from observational data: Are marginal structural models the solutions?
September 19, 2008, 12pm - Marcio Machado: Transferability of economic evaluations across jurisdictions: ISPOR good research practices task force report
September 5, 2008, 12pm - Robert Fowler: Challenges in the economic evaluation of the E-PROJECT study
July 11, 2008, 12pm - Farah Farahati: Recent Developments in Decision-Analytic Modelling for Economic Evaluation